SmartFSCV: An Artificial Intelligence Enabled Miniaturised FSCV Device Targeting Serotonin
Dean M Corva1, Egan H Doeven2, Brenna Parke3
1School of EngineeringDeakin University Geelong VIC 3216 Australia.
IEEE Open Journal of Engineering in Medicine and Biology
|March 15, 2024
Summary
A new device, SmartFSCV, enables real-time serotonin monitoring in the brain. This portable technology uses fast-scan cyclic voltammetry (FSCV) and artificial intelligence (AI) for improved neurological disorder diagnosis.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Analytical Chemistry
Background:
- Dynamic monitoring of serotonin in brain regions is crucial for diagnosing and treating neurological and psychiatric disorders.
- Current serotonin measurement techniques are not immediate, portable, or cost-effective, hindering clinical applications.
- There is a need for advanced, miniaturized devices for real-time in vivo neurotransmitter analysis.
Purpose of the Study:
- To develop and validate a miniaturized device, SmartFSCV, for real-time dynamic monitoring of serotonin.
- To assess the device's performance in sensing serotonin using fast-scan cyclic voltammetry (FSCV).
- To integrate artificial intelligence (AI) for enhanced data analysis and decision-making regarding serotonin presence.
Main Methods:
- Development of SmartFSCV, a miniaturized device employing fast-scan cyclic voltammetry (FSCV).
- The device operates within a -3 to +3 V potential range and measures current with nano-ampere accuracy.
- Utilized a specific N-shaped waveform at 1000 V/s for serotonin sensing, with modifiable arbitrary waveform capabilities.
Main Results:
- Validation through static bench testing and dynamic serotonin level monitoring.
- Successful application of artificial intelligence (AI) algorithms for data interpretation.
- Demonstrated the device's capability to accurately sense serotonin and inform decisions.
Conclusions:
- SmartFSCV successfully and accurately senses serotonin in real-time.
- The integration of AI algorithms enhances the device's ability to make informed decisions about serotonin presence.
- This technology holds promise for improving diagnostic and therapeutic strategies for brain disorders.


